(Q28239522)

1

0 references

Xueqing Zhang

2

0 references

Lingling Wu

3

0 references

Jeanine D Mattson

4

0 references

Taiying Chen

5

0 references

Kathy Smith

6

0 references

Beth Basham

7

0 references

Terrill McClanahan

8

0 references

Robert A Kastelein

9

0 references

Martin Oft

Inflammation and cancer: back to Virchow?

10

0 references

language of work or name

English

0 references

publication date

27 July 2006

0 references

published in

Nature

0 references

volume

442

0 references

issue

7101

0 references

page(s)

461-5

0 references

cites work

1 reference

21 January 2018

Inflammation and cancer

1 reference

The immunobiology of cancer immunosurveillance and immunoediting

21 January 2018

1 reference

Modulating T-cell immunity to tumours: new strategies for monitoring T-cell responses

21 January 2018

1 reference

Cancer immunotherapy: a treatment for the masses

21 January 2018

1 reference

Tumors as elusive targets of T-cell-based active immunotherapy

21 January 2018

1 reference

Mini-review: overcoming tumor-intrinsic resistance to immune effector function.

21 January 2018

1 reference

IL-12 and IL-23: master regulators of innate and adaptive immunity.

21 January 2018

1 reference

Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12

21 January 2018

1 reference

A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R

21 January 2018

1 reference

Interleukin 17-producing CD4 effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

21 January 2018

1 reference

Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17

21 January 2018

1 reference

Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain

21 January 2018

1 reference

IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

21 January 2018

1 reference

The distinct contributions of murine T cell receptor (TCR)gammadelta and TCRalphabeta T cells to different stages of chemically induced skin cancer

21 January 2018

1 reference

Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17.

21 January 2018

1 reference

Autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor in human gliomas with tumor progression

21 January 2018

1 reference

MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis

21 January 2018

1 reference

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

21 January 2018

1 reference

Interleukin-12 and the regulation of innate resistance and adaptive immunity

21 January 2018

1 reference

Antitumor and antimetastatic activity of IL-23

21 January 2018

1 reference

IL-23 provides a limited mechanism of resistance to acute toxoplasmosis in the absence of IL-12.

21 January 2018

1 reference

IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available

21 January 2018

1 reference

Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris

21 January 2018

1 reference

A subset of skin tumor modifier loci determines survival time of tumor-bearing mice.

21 January 2018

1 reference

Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice.

21 January 2018

1 reference

Interleukin-17 promotes angiogenesis and tumor growth

21 January 2018

1 reference